BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23886743)

  • 1. Intramedullary spinal cord metastases: visibility on PET and correlation with MRI features.
    Mostardi PM; Diehn FE; Rykken JB; Eckel LJ; Schwartz KM; Kaufmann TJ; Wood CP; Wald JT; Hunt CH
    AJNR Am J Neuroradiol; 2014 Jan; 35(1):196-201. PubMed ID: 23886743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramedullary spinal cord metastases: MRI and relevant clinical features from a 13-year institutional case series.
    Rykken JB; Diehn FE; Hunt CH; Schwartz KM; Eckel LJ; Wood CP; Kaufmann TJ; Lingineni RK; Carter RE; Wald JT
    AJNR Am J Neuroradiol; 2013 Oct; 34(10):2043-9. PubMed ID: 23620071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramedullary spinal cord metastases: prognostic value of MRI and clinical features from a 13-year institutional case series.
    Diehn FE; Rykken JB; Wald JT; Wood CP; Eckel LJ; Hunt CH; Schwartz KM; Lingineni RK; Carter RE; Kaufmann TJ
    AJNR Am J Neuroradiol; 2015 Mar; 36(3):587-93. PubMed ID: 25395656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradural intramedullary spinal cord metastasis due to mesothelioma.
    Chamberlain MC; Eaton KD; Fink JR; Tredway T
    J Neurooncol; 2010 Mar; 97(1):133-6. PubMed ID: 19693437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.
    Flanagan EP; Hunt CH; Lowe V; Mandrekar J; Pittock SJ; O'Neill BP; Keegan BM
    Mayo Clin Proc; 2013 Nov; 88(11):1204-12. PubMed ID: 24182701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
    Botsikas D; Kalovidouri A; Becker M; Copercini M; Djema DA; Bodmer A; Monnier S; Becker CD; Montet X; Delattre BM; Ratib O; Garibotto V; Tabouret-Viaud C
    Eur Radiol; 2016 Jul; 26(7):2297-307. PubMed ID: 26477029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rim and flame signs: postgadolinium MRI findings specific for non-CNS intramedullary spinal cord metastases.
    Rykken JB; Diehn FE; Hunt CH; Eckel LJ; Schwartz KM; Kaufmann TJ; Wald JT; Giannini C; Wood CP
    AJNR Am J Neuroradiol; 2013 Apr; 34(4):908-15. PubMed ID: 23079405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptomeningeal carcinomatosis and intramedullary spinal cord metastases from lung cancer: detection with FDG positron emission tomography.
    Komori T; Delbeke D
    Clin Nucl Med; 2001 Nov; 26(11):905-7. PubMed ID: 11595839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET findings of intramedullary tumors of the spinal cord using [18F] FDG and [11C] methionine.
    Tomura N; Ito Y; Matsuoka H; Saginoya T; Numazawa SI; Mizuno Y; Watanabe K
    AJNR Am J Neuroradiol; 2013; 34(6):1278-83. PubMed ID: 23275592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
    Botsikas D; Bagetakos I; Picarra M; Da Cunha Afonso Barisits AC; Boudabbous S; Montet X; Lam GT; Mainta I; Kalovidouri A; Becker M
    Eur Radiol; 2019 Apr; 29(4):1787-1798. PubMed ID: 30267154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord metastases from lung cancer: detection with F-18 FDG PET/CT.
    Nguyen NC; Sayed MM; Taalab K; Osman MM
    Clin Nucl Med; 2008 May; 33(5):356-8. PubMed ID: 18431157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver Metastases.
    Zhang C; O'Shea A; Parente CA; Amorim BJ; Caravan P; Ferrone CR; Blaszkowsky LS; Soricelli A; Salvatore M; Groshar D; Bernstine H; Domachevsky L; Canamaque LG; Umutlu L; Ken H; Catana C; Mahmood U; Catalano OA
    Invest Radiol; 2021 Oct; 56(10):621-628. PubMed ID: 33813576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis.
    Sakushima K; Yabe I; Shiga T; Yashima-Yamada M; Tsuji-Akimoto S; Terae S; Sasaki H
    J Neurol; 2011 Feb; 258(2):227-30. PubMed ID: 20820799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
    Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
    Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramedullary spinal cord metastases, mainly of nonneurogenic origin.
    Post MJ; Quencer RM; Green BA; Montalvo BM; Tobias JA; Sowers JJ; Levin IH
    AJR Am J Roentgenol; 1987 May; 148(5):1015-22. PubMed ID: 3554916
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
    Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.